CRH plc (CRH) Stock Price & Analysis
CRH plc (CRH) closed at USD 86.43 on Thursday, October 22, 2026, up 0.46% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 86.03; the Oct 22, 2026 session ranged USD 84.59–86.82 on volume of 4,501,257 shares. Market capitalization is $57.50B, with a 52-week range of USD 78.62–131.55 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:23 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CRH.md
Key facts (CRH)
- Last four reported quarters (through Jun 30, 2026): revenue $38.6B, net income $3.84B (9.9% margin), free cash flow $2.77B (SEC filings).
- Valuation: P/E 15.0x (avg 18.9x at the last 3 fiscal year-ends), net debt $14.8B.
- 4 of 80 tracked superinvestors hold CRH (13F, Q2 2026 (1 investor on Q3 2026, filed early)): 0 new, 2 added, 2 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $156K; 1 not under a Rule 10b5-1 plan ($156K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.78 on a 1–5 scale) (23 analysts), mean target USD 122.72 (range 96–160).
- Total return with dividends: 1Y -25.9% vs S&P 500 +14.9%; 5Y +108.0% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 2.03, revenue estimate $11.6B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CRH)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $29.2B | $32.7B | $34.9B | $35.6B | $37.4B | $38.6B |
| Gross profit | $9.83B | $10.8B | $12.0B | $12.7B | $13.5B | — |
| Operating income | $3.33B | $3.81B | $4.19B | $4.92B | $5.44B | $5.53B |
| Net income | $2.63B | $3.86B | $3.18B | $3.49B | $3.75B | $3.84B |
| EPS (diluted) | $3.32 | $5.11 | $4.33 | $5.02 | $5.51 | — |
| Free cash flow | $2.42B | $2.28B | $3.20B | $2.41B | $2.91B | $2.77B |
| Gross margin | 33.6% | 33.1% | 34.2% | 35.7% | 36.1% | — |
| Operating margin | 11.4% | 11.6% | 12.0% | 13.8% | 14.5% | 14.3% |
| Net margin | 9.0% | 11.8% | 9.1% | 9.8% | 10.0% | 9.9% |
| Revenue growth | — | +12.0% | +6.8% | +1.8% | +5.3% | — |
| Cash + short-term investments | $5.78B | $5.94B | $6.34B | $3.72B | $4.10B | — |
| Total debt | — | $9.54B | $11.5B | $13.9B | $17.5B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CRH)
P/E 15.0x · P/S 1.5x · EV/Sales 1.9x · P/FCF 20.8x · P/B 2.4x · FCF yield 4.81% · Earnings yield 6.67% · Buyback yield (TTM) 1.99% · Net debt $14.8B · EV $72.3B
P/E at fiscal year-ends: Dec 2025 22.5x, Dec 2024 18.3x, Dec 2023 15.9x.
Superinvestors (SEC 13F-HR, Q2 2026) (CRH)
4 of 80 tracked investors hold CRH (1 investor on Q3 2026, filed early). Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change | Quarter |
|---|---|---|---|---|---|
| Daniel Loeb | Third Point | 5.06% | $235M | Added +15.5% | Q2 2026 |
| John Armitage | Egerton Capital | 3.06% | $301M | Reduced -17.2% | Q3 2026 |
| Henry Ellenbogen | Durable Capital Partners | 2.77% | $285M | Added +80.4% | Q2 2026 |
| First Eagle Investment | First Eagle Investment Management | <0.01% | $310K | Reduced -2.4% | Q2 2026 |
Insider sales (SEC Form 4, open-market, last ~7 months) (CRH)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Oriordain Padraig | See Remarks | 1,492 | $156K | 55.3% | No | Too little history (no open-market trades in 2023 or 2024) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (CRH)
Consensus Buy (mean 1.78 on a 1–5 scale), 23 analysts; mean target USD 122.72 (low 96, high 160).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Barclays | Target lowered | Overweight | $131 → $110 |
| 2026-10-09 | RBC Capital | Target lowered | Outperform | $165 → $135 |
| 2026-10-05 | Wells Fargo | Target lowered | Overweight | $107 → $106 |
| 2026-10-05 | Truist Securities | Target lowered | Buy | $130 → $105 |
| 2026-10-02 | Citigroup | Target lowered | Buy | $122 → $106 |
| 2026-09-22 | UBS | Target lowered | Buy | $147 → $135 |
| 2026-09-09 | Wells Fargo | Target lowered | Overweight | $132 → $107 |
| 2026-08-25 | DA Davidson | Initiated | Buy | $137 |
| 2026-07-31 | Stephens & Co. | Target lowered | Overweight | $135 → $125 |
| 2026-07-31 | Truist Securities | Target lowered | Buy | $140 → $130 |
| 2026-07-08 | Wells Fargo | Target lowered | Overweight | $135 → $132 |
| 2026-06-26 | Jefferies | Target raised | Buy | $149 → $165.6 |
Total return (dividends reinvested) (CRH)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -25.9% | +108.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -25.9% | +15.7% |
| Volatility (annualized) | 32.3% | 29.9% |
| Max drawdown | -39.0% (Jan 2026→Oct 2026) | -37.2% (Jan 2026→Oct 2026) |
CRH revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Americas Materials Solutions | $4.96B | 46.0% | +9.9% |
| International Solutions | $3.70B | 34.4% | +4.7% |
| Americas Building Solutions | $2.12B | 19.6% | -1.9% |
| Total revenue | $10.78B | 100% | — |
CRH revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Product | $8.49B | 78.8% | +7.2% |
| Road Solutions | $3.32B | 30.8% | +5.6% |
| Service | $2.29B | 21.2% | -0.0% |
| Essential Materials | $1.64B | 15.2% | +20.0% |
| Total revenue | $10.78B | 100% | — |
CRH revenue by region (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| UNITED STATES | $22.83B | 61.0% | +4.6% |
| Rest Of Europe | $7.37B | 19.7% | +5.0% |
| United Kingdom | $3.77B | 10.1% | -5.7% |
| Rest Of World | $3.47B | 9.3% | +27.7% |
| Total revenue | $37.45B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
CRH company outlook (results filed Jul 30, 2026)
- “Outlook positive; expecting another year of growth underpinned by our superior strategy and connected portfolio • Reaffirming FY26 guidance for Net income ($3.9bn-$4.1bn), Adj.”
- “Notwithstanding current geopolitical and macroeconomic uncertainties, we remain encouraged by the underlying demand across our key markets and are pleased to reaffirm our guidance for 2026 Net income, Adjusted EBITDA* and Diluted EPS, leaving us well positioned to deliver another year of growth and value creation." Summary Financials Q2 2026 YOY Change Total revenues $10.8bn +6% N”
Quoted word-for-word from the SEC 8-K results press release.
CRH analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.03 | $2.42 | -15.9% | $11.56B | 6 |
| Next quarter (ends Dec 2026) | $1.53 | $1.62 | -5.2% | $9.76B | 6 |
| Current fiscal year (ends Dec 2026) | $5.57 | $5.95 | -6.3% | $39.60B | 13 |
| Next fiscal year (ends Dec 2027) | $6.29 | $6.78 | -7.2% | $41.75B | 16 |
Key Statistics (as of October 23, 2026 at 09:23 UTC)
| Price | USD 86.43 |
|---|---|
| Change | ▲ 0.46% (up) |
| Previous Close | USD 86.03 |
| Open | USD 85.41 |
| Day Range | USD 84.59 – 86.82 |
| 52-Week Range | USD 78.62 – 131.55 |
| Volume | 4,501,257 shares |
| Market Cap | $57.50B |
| Exchange | NYQ |
Technical Analysis (CRH)
Nexqual's technical model rates CRH "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of October 23, 2026 at 09:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 52.63 (neutral) |
| vs SMA50 | Below (USD 88.14) |
| MACD | -0.91 (negative) |
Analyst Ratings (CRH)
Wall Street analysts rate CRH "Buy" based on 23 analysts, with a mean price target of USD 122.72 (range USD 96–160), per Nexqual as of October 23, 2026 at 09:23 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 23 |
| Mean Target | USD 122.72 |
| High Target | USD 160 |
| Low Target | USD 96 |
| Buy / Hold / Sell | 22 / 1 / 0 |
Earnings (CRH)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 2.03 |
| Revenue Estimate | $11.56B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.93 vs est 2.02 ▼ miss |
| 2026-03-31 | USD -0.21 vs est -0.23 ▲ beat |
| 2025-12-31 | USD 1.51 vs est 1.53 ▼ miss |
| 2025-09-30 | USD 2.23 vs est 2.21 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Financials & Fundamentals (CRH)
| Total Revenue | $38.63B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +5.60% |
| Gross Margin | +36.25% |
| Operating Margin | +19.02% |
| Profit Margin | +9.94% |
| ROE | +15.81% |
| Debt / Equity | 0.78 |
| Current Ratio | 1.58 |
| Total Cash | $3.02B |
| Total Debt | $19.81B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $2.77B (7.2% of revenue) |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Financial Health Score (CRH)
Nexqual rates CRH plc's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:23 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 36%, operating 19% (last 12 months) |
| Balance Sheet | Mixed — $3.02B cash and investments vs $17.8B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $2.77B (last 4 quarters to Jun 2026, SEC), 7% margin |
| Efficiency | Solid — ROE 16%, ROA 6.1% |
Ownership (CRH)
| Insider Ownership | +0.14% |
|---|---|
| Institutional Ownership | +88.37% |
| Shares Outstanding | 665.28M |
| Float | 663.44M |
| Short % of Float | +2.16% |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Leadership (CRH)
CRH plc is led by Jim Mintern, CEO & Director, per Nexqual as of October 23, 2026 at 09:23 UTC.
| CEO & Director | Jim Mintern |
|---|---|
| Chief Operating Officer | Randy Lake |
| President of Americas Division | Nathan Creech |
| President of International Division | Peter Buckley |
| Chief Financial Officer | Aylwyn Bryan |
Major Backers & Investors (CRH)
Notable institutional backers of CRH plc include FMR, LLC, Massachusetts Financial Services Co., Franklin Resources, Inc., according to Nexqual as of October 23, 2026 at 09:23 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 5.71% |
| Massachusetts Financial Services Co. | 2.04% |
| Franklin Resources, Inc. | 2.04% |
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 1.99% |
| Boston Partners | 1.94% |
| Fidelity | 1.3% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.42% |
| BlackRock | 8.11% |
| State Street | 4.29% |
| Geode Capital | 2.28% |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
From CRH plc's Latest SEC 10-K Filing (filed 2026-02-18)
Key Strengths & Strategy (as disclosed to the SEC)
- As part of its vertically integrated business model, the raw materials from these quarries are used to manufacture primary building materials, such as aggregates, cement, asphalt, readymixed concrete and concrete products, which are offered directly for sale or integrated into downstream products and services.
- Together with our Essential Materials businesses, we have developed our roads offering to provide customers with quality, flexibility, speed, expertise and convenience through our deep market knowledge and highly capable team of professionals.
- Our locally-led, globally-enabled approach and our leading performance model enable us to innovate across diverse geographies and markets, where it matters most for our customers.
Partnerships
- CRH Ventures, our venture capital arm, works in partnership with start-ups, industry players, and academic institutions to pilot and scale cutting-edge technologies and accelerate progress towards a more resilient built environment.
- Our strategic investment in VODA.ai expands our capabilities in water asset management with Artificial Intelligence (AI)-driven technology.
Legal & Regulatory Risks (Item 1A, quoted)
- Laws, Regulations and Business Conduct
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MLM | Martin Marietta Materials, Inc. | USD 517.67 | ▲ 1.7% |
| VMC | Vulcan Materials Company (Holdi | USD 268.72 | ▲ 1.54% |
| AMRZ | Amrize Ltd | USD 39.44 | ▲ 1.65% |
| JHX | James Hardie Industries plc. | USD 26.54 | ▲ 0.91% |
| CX | Cemex, S.A.B. de C.V. Sponsored | USD 10.11 | ▼ 2.69% |
| EXP | Eagle Materials Inc | USD 178.74 | ▲ 3.09% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:23 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt